000 01211 a2200337 4500
005 20250516025958.0
264 0 _c20110630
008 201106s 0 0 eng d
022 _a1555-905X
024 7 _a10.2215/CJN.06710810
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDavin, Jean-Claude
245 0 0 _aHenoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy.
_h[electronic resource]
260 _bClinical journal of the American Society of Nephrology : CJASN
_cMar 2011
300 _a679-89 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aDisease Progression
650 0 4 _aEvidence-Based Medicine
650 0 4 _aHumans
650 0 4 _aIgA Vasculitis
_xcomplications
650 0 4 _aKidney
_xpathology
650 0 4 _aNephritis
_xetiology
650 0 4 _aPatient Selection
650 0 4 _aRisk Assessment
650 0 4 _aRisk Factors
650 0 4 _aSeverity of Illness Index
650 0 4 _aTreatment Outcome
773 0 _tClinical journal of the American Society of Nephrology : CJASN
_gvol. 6
_gno. 3
_gp. 679-89
856 4 0 _uhttps://doi.org/10.2215/CJN.06710810
_zAvailable from publisher's website
999 _c20665628
_d20665628